ABI SimpliAmp A24812 PCR Thermal Cycler 2017 Standalone Laboratory
Applied Biosystems
Details
-
CategoryMolecular Biology
-
Dimension19.0in x 10.0in x 9.0in
-
Serial228009524
-
Shipping TypeFedEx Ground
-
Manufacturing2017-05-29
-
Voltage / Hertz100-240V / 50Hz/60Hz
Description
The ABI SimpliAmp Thermal Cycler A24812, manufactured in 2017, is a sophisticated PCR machine designed for precise and efficient DNA amplification. This standalone thermal cycler operates with a voltage range of 100-240V and frequency of 50Hz/60Hz, making it adaptable to various laboratory environments. With a very good condition rating, it functions well with minimal cosmetic imperfections, ensuring reliable performance. The cycler has passed all self-tests and is suitable for a wide range of molecular biology applications, such as gene expression analysis or cloning. While it comes with a power cord, additional computer or software is not included, allowing flexibility in IT integration.
Technician comment
Self test run and Pass without issues. Has slight cosmetic blemishes from normal use. See photos
Key Features
- Standalone PCR Thermal Cycler
- Adaptable to 100-240V, 50Hz/60Hz power input
- Minimal cosmetic wear with verified functional capability
- Ideal for DNA amplification and gene expression analysis
Specifications
- Voltage: 100-240V
- Frequency: 50Hz/60Hz
- Manufacture Year: 2017
- Condition: Very Good (VG)
- Includes: Power Cord
- Dimensions: Length 19.0 in x Width 10.0 in x Height 9.0 in (metric in cm equivalent)
Weight
Imperial: 24.0 Pounds
Metric: 10.89 Kilograms
Shipping Dimensions
Imperial: 22.8 lb x 12.0 lb x 10.8 lb
Metric: 57.91 cm x 30.48 cm x 27.43 cm
Harmonized Code
841989
Harmonized Code Details
841989 is for other machinery, plant, or laboratory uses where temperature change is significant. This code is applicable as the SimpliAmp A24812 is a thermal PCR cycler primarily used in laboratories for biotechnological processes, including temperature-controlled DNA amplification.
Comments 0
There are currently no public comments.